Thirty years on hemodialysis: One patient's story

被引:0
作者
Gradden, C [1 ]
Ahmad, R [1 ]
机构
[1] Royal Liverpool Univ Hosp, Renal Unit, Liverpool, Merseyside, England
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The prognosis for patients starting dialysis continues to improve with advances in medical technology and a greater understanding of the pathological processes that accompany end-stage renal failure. At the time when chronic dialysis facilities were first being set up more than 30 years ago, the outlook for patients entering such programs was far less optimistic. Mortality rates, even for young patients, were high, and only with the development of transplant programs did there appear to be any cause for optimism that long-term survival could be achieved. Most patients who survive end-stage renal failure for more than 15 years are likely to have their history interrupted with at least one transplant and, possibly, the use of different forms of dialysis, both peritoneal and hemodialysis. However, with the greater recognition of the problems of atherosclerosis, cardiovascular disease, anemia, renal osteodystrophy, and dialysis-related problems, as well as the targeting of specific strategies toward these processes, it has become evident that long-term survival on dialysis, with good qualify of life, is a realistic goal. We represent a man who has survived more than 30 years on hemodialysis, and who has never had a successful renal transplant or used any other form of renal replacement therapy. He now has all of the complications of prolonged chronic renal failure, but he has witnessed and has become apart of, the history of modern renal replacement therapy as one of the longest, if not the longest, surviving patients in Europe on uninterrupted hemodialysis.
引用
收藏
页码:374 / +
页数:4
相关论文
共 10 条
  • [1] AHMAD R, 1983, BRIT J HOSP MED, V29, P95
  • [2] 1,25(OH)2D3 ADMINISTRATION IN MODERATE RENAL-FAILURE - A PROSPECTIVE DOUBLE-BLIND TRIAL
    BAKER, LRI
    ABRAMS, SML
    ROE, CJ
    FAUGERE, MC
    FANTI, P
    SUBAYTI, Y
    MALLUCHE, HH
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (02) : 661 - 669
  • [3] Water quality and complications of haemodialysis
    Brunet, P
    Berland, Y
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (05) : 578 - 580
  • [4] Chesser AMS, 1999, CLIN NEPHROL, V51, P228
  • [5] THE ROLE OF ACETATE IN THE ETIOLOGY OF SYMPTOMATIC HYPOTENSION
    KESHAVIAH, PR
    [J]. ARTIFICIAL ORGANS, 1982, 6 (04) : 378 - 384
  • [6] LONG-TERM CARDIORESPIRATORY EFFECTS OF AMELIORATION OF RENAL ANEMIA BY ERYTHROPOIETIN
    MACDOUGALL, IC
    LEWIS, NP
    SAUNDERS, MJ
    COCHLIN, DL
    DAVIES, ME
    HUTTON, RD
    FOX, KAA
    COLES, GA
    WILLIAMS, JD
    [J]. LANCET, 1990, 335 (8688) : 489 - 493
  • [7] Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
    Rostand, SG
    Drüeke, TB
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (02) : 383 - 392
  • [8] Morbidity and mortality reduction associated with the use of erythropoietin
    Tsakiris, D
    [J]. NEPHRON, 2000, 85 : 2 - 8
  • [9] Wada T, 1999, PERITON DIALYSIS INT, V19, pS413
  • [10] Improved outcome for haemodialysis patients treated with high-flux membranes
    Woods, HF
    Nandakumar, M
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 36 - 42